Acacia Pharma ^Delisted

Acacia Pharma is a commercial stage biopharmaceutical group that focuses on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy. They have a portfolio of differentiated hospital products primarily for use by anesthesia and surgical teams, as well as a late-stage development candidate targeting oncologists. Acacia Pharma commercializes its current products directly in the US through its own commercial organization, specifically targeting anesthesia and surgical teams. Their main goal is to transform medicine and advance care by providing innovative solutions for supportive care in cancer patients and other medical treatments.